Smoking cessation 2008

Research output: Contribution to journalArticle

Abstract

The Smoking Cessation 2008 conference demonstrated that, although various treatments are currently available (eg, NRT, bupropion and varenicline) and constitute a large market, only one in five smokers will succeed in quitting smoking for 12 months. In addition to the scope for novel pharmaceutical products, the importance of counseling during attempts at quitting was a recurrent theme at the conference; physicians and pharmacists have a key role in providing support. Marketing, legislation and community health initiatives all further contribute to the incentives that encourage smokers to attempt to quit.
LanguageEnglish
Pages256-259
Number of pages4
JournalIDrugs
Volume11
Issue number4
StatusPublished - Apr 2008

Fingerprint

Smoking Cessation
Bupropion
Marketing
Legislation
Pharmacists
Motivation
Counseling
Smoking
Physicians
Pharmaceutical Preparations
Therapeutics
Varenicline

Cite this

Smoking cessation 2008. / Wonnacott, S.

In: IDrugs, Vol. 11, No. 4, 04.2008, p. 256-259.

Research output: Contribution to journalArticle

Wonnacott, S 2008, 'Smoking cessation 2008' IDrugs, vol. 11, no. 4, pp. 256-259.
Wonnacott S. Smoking cessation 2008. IDrugs. 2008 Apr;11(4):256-259.
Wonnacott, S. / Smoking cessation 2008. In: IDrugs. 2008 ; Vol. 11, No. 4. pp. 256-259
@article{77a88a3a62904b23a6fcd96541ba0640,
title = "Smoking cessation 2008",
abstract = "The Smoking Cessation 2008 conference demonstrated that, although various treatments are currently available (eg, NRT, bupropion and varenicline) and constitute a large market, only one in five smokers will succeed in quitting smoking for 12 months. In addition to the scope for novel pharmaceutical products, the importance of counseling during attempts at quitting was a recurrent theme at the conference; physicians and pharmacists have a key role in providing support. Marketing, legislation and community health initiatives all further contribute to the incentives that encourage smokers to attempt to quit.",
author = "S Wonnacott",
year = "2008",
month = "4",
language = "English",
volume = "11",
pages = "256--259",
journal = "IDrugs",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "4",

}

TY - JOUR

T1 - Smoking cessation 2008

AU - Wonnacott,S

PY - 2008/4

Y1 - 2008/4

N2 - The Smoking Cessation 2008 conference demonstrated that, although various treatments are currently available (eg, NRT, bupropion and varenicline) and constitute a large market, only one in five smokers will succeed in quitting smoking for 12 months. In addition to the scope for novel pharmaceutical products, the importance of counseling during attempts at quitting was a recurrent theme at the conference; physicians and pharmacists have a key role in providing support. Marketing, legislation and community health initiatives all further contribute to the incentives that encourage smokers to attempt to quit.

AB - The Smoking Cessation 2008 conference demonstrated that, although various treatments are currently available (eg, NRT, bupropion and varenicline) and constitute a large market, only one in five smokers will succeed in quitting smoking for 12 months. In addition to the scope for novel pharmaceutical products, the importance of counseling during attempts at quitting was a recurrent theme at the conference; physicians and pharmacists have a key role in providing support. Marketing, legislation and community health initiatives all further contribute to the incentives that encourage smokers to attempt to quit.

UR - http://www.scopus.com/inward/record.url?scp=41649113721&partnerID=8YFLogxK

UR - http://www.biomedcentral.com/1369-7056/11?issue=4

M3 - Article

VL - 11

SP - 256

EP - 259

JO - IDrugs

T2 - IDrugs

JF - IDrugs

SN - 1369-7056

IS - 4

ER -